✦ LIBER ✦

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

✍ Scribed by Farley, John; Brady, William E; Vathipadiekal, Vinod; Lankes, Heather A; Coleman, Robert; Morgan, Mark A; Mannel, Robert; Yamada, S Diane; Mutch, David; Rodgers, William H; Birrer, Michael; Gershenson, David M

Book ID: 122610562
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 148 KB
Volume: 14
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(12)70572-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of imatinib mesylate in p

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube

✍ Ignacio Romero Noguera; Charlotte C. Sun; Russell R. Broaddus; Donna Branham; Ch 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Olaparib in patients with recurrent high

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

✍ Karen A Gelmon; Marc Tischkowitz; Helen Mackay; Kenneth Swenerton; André Robidou 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 264 KB

Open-label, single-arm phase II study of

Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy

✍ Yang Zhang, Liping Zhao, Peiyu Huang, Jingxun Wu… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 201 KB